Product logins

Find logins to all Clarivate products below.


Archita Kukreja

M.B.A., M.S., Lead Healthcare Research & Data Analyst

Archita has authored reports on hematological indications like beta thalassemia and sickle cell disease, infectious diseases and several niche and rare indications. Prior to joining Clarivate, she was a Manager at Sanofi. She has worked on diverse custom and syndicated research project types in several therapeutic areas and has experience in sales- and epidemiology-based forecasting, demand forecasting, commercial opportunity assessments, and market intelligence. She holds double master’s degrees in business administration (M.B.A) and in Science (M.S.) with specialization in Biotechnology from Amity University, Noida, India and Jamia Millia Islamia University, Delhi, India, respectively.

Latest news

News September 9, 2026
Clarivate Pulse of the Library 2026 Report Reveals AI Adoption Gaps Across Geographies, Mainland China Advancing Fastest

Organizational readiness, regional differences and evolving priorities are shaping the landscape of AI adoption in libraries London, U.K. September 9, 2026 – Clarivate Plc (NYSE:CLVT), a leading global provider of…

News August 26, 2026
Clarivate Updates Social Media Channels for Library Communities

Ex Libris and Innovative channels will become Clarivate for Academic Libraries and Clarivate for Public Libraries LONDON, UK, August 26, 2026 – Clarivate Plc (NYSE: CLVT), a leading global provider…

Partner news August 17, 2026
ShanghaiRanking’s Academic Ranking of World Universities 2026 Press Release

The 2026 Academic Ranking of World Universities (ARWU) is released today by ShanghaiRanking Consultancy. Since 2003, ARWU has been presenting the world’s top universities annually based on transparent methodology and…

Partner news

Related resources

Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
Blog June 24, 2026
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
ADC Biopharma Biotech Bispecific antibodies BsAb Clinical trials Development Oncology Pharma R&D Regulatory Research
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Blog June 22, 2026
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Biopharma Biotech Clinical trials CMC Development R&D Real-World Data Regulatory Research Safety
Three uncomfortable truths about cell and gene therapy in regulatory affairs Three uncomfortable truths about cell and gene therapy in regulatory affairs
Blog May 28, 2026
Three uncomfortable truths about cell and gene therapy in regulatory affairs
Consulting Resource Center Regulatory
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization Consulting Resource Center FDA HMO Insurance Launch Managed care Market Access North America Payer Pharma pricing Route of administration U.S.